Molecular typing is predicated on molecular genetic tests and isn't however routinely available. Molecular subtypes and immunohistochemical surrogate markers in the tumors (HR, HER2, triple destructive) correlate in about 70%. The differentiation of luminal A and B subtypes by HR standing and proliferation markers like Ki-67 might be valuable, https://popeo653teo4.wikitelevisions.com/user